GAMMA Investing’s Lexeo Therapeutics LXEO Stock Holding History

GAMMA Investing’s Portfolio LXEO Stock Details LXEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.15K	Buy	340 +93	+38%	+$421	﹤0.01%	4075
2026 Q2	$1.15K	Sell	247 -84	-25%	-$454	﹤0.01%	3852
2026 Q1	$1.9K	Buy	331 +281	+562%	+$1.99K	﹤0.01%	3680
2025 Q4	$497	Buy	+50	New	+$456	﹤0.01%	3914
2025 Q1	–	Sell	-245	Closed	-$1.61K	–	3843
2024 Q4	$1.61K	Buy	+245	New	+$1.93K	﹤0.01%	3287
2024 Q3	–	Sell	-14	Closed	-$225	–	3626
2024 Q2	$225	Buy	+14	New	+$203	﹤0.01%	3310

Other funds holding LXEO

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's LXEO Position: Q3 2026 in Review

GAMMA Investing increased its Lexeo Therapeutics (LXEO) stake by 38% in Q3 2026, buying an estimated $421 and bringing the position to 340 shares worth $1.15K. The position accounts for ﹤0.01% of the portfolio, ranked #4075.

GAMMA Investing first reported a position in LXEO in Q2 2024 and has held it in 6 quarters since. The position peaked at $1.9K in Q1 2026. 2 funds tracked by Wall St. Rank hold LXEO as of Q3 2026.

GAMMA Investing held 340 shares of Lexeo Therapeutics worth $1.15K as of Q3 2026.
GAMMA Investing bought 93 Lexeo Therapeutics shares in Q3 2026, an estimated $421.
Lexeo Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #4075 holding.
GAMMA Investing first reported a position in Lexeo Therapeutics in Q2 2024 and has held it in 6 quarters since.
GAMMA Investing's Lexeo Therapeutics position peaked at $1.9K in Q1 2026.
2 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.